SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 56.61-0.6%Nov 6 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (6)2/25/1999 8:38:00 AM
From: BRAVEHEART  Read Replies (1) of 52153
 
Hi Gang,

Mike careful what you wish for. Ever hear of the Butterfly Flapping it's wings story where halfway across the globe it causes a Hurricane.

Anyway more to the point. Valuation is a frustrating concept. Some days I muse over Analyst reports and I ask my self, "What are/were they thinking". For instance PGEN and it's acquisition which was valued at $30 million of IPO money. It will be interesting to see how little they get for the same ( improved upon? ) assets today.

For those looking to add to that Frustration you may want to get a copy of the recent Nature Biotechnology Issue along with it's supplement. It goes into considerable detail on the financing of biotech. Which to me is a large percentage of the construct in valuating any specific biotech. Especially the the early stage third tier companies.

For even more theoretical constructs on models which are often used in determining valuation one might pick up the following two part article ( Even a photocopy ) from IN VIVO. The title is Biotech Models, Part I : Near-Term Stratigies & Biotech Models, Part II : Early-Stage Companies. The two issues needed are Vol 14 #11 December 1996 & the January 1997 issue. Interesting reading in the least.

Best Wishes
Jeffrey

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News